StockPriceToday
Arbutus Biopharma Corporation (ABUS)
About Arbutus Biopharma Corporation
Arbutus Biopharma Corporation operates as a clinical-stage biotechnology company dedicated to developing innovative therapies for chronic hepatitis B virus (HBV) infection. The company's specialized focus on HBV treatment makes ABUS stock price particularly sensitive to clinical trial results and developments in hepatitis B therapy.
The company's research pipeline includes novel approaches to achieving functional cures for chronic HBV infection, addressing a significant global health challenge affecting millions of patients worldwide. ABUS's drug development programs target different aspects of the HBV lifecycle, including viral replication, immune system activation, and viral antigen reduction.
Investors tracking ABUS stock price monitor the company's progress through clinical development, as successful hepatitis B treatments represent substantial commercial opportunities given the large global patient population and limited current treatment options for achieving functional cures.
Arbutus Biopharma's intellectual property portfolio includes important patents related to lipid nanoparticle technology used in various drug delivery applications. The company's licensing agreements and partnerships provide additional revenue streams that support business operations and influence ABUS stock price stability while advancing its hepatitis B therapeutic programs.
ABUS Stock 12 Month Chart
Latest News for ABUS
On October 22, 2026, Arbutus Biopharma Corporation announced that the U.S. Food and Drug Administration has lifted the clinical hold on the Investigational New Drug application for AB-101, the Company ...
Arbutus Biopharma is now much better capitalized after Moderna validated the value of its LNP patents. As for ABUS’ in-house assets, I think Imdusiran has shown durable viral control. The main caveat ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Other Popular Stocks
Relmada Therapeutics Inc. (RLMD) is a clinical-stage biotechnology company developing novel therapies for central nervous system diseases, with a focus on addressing unmet needs...
Pinnacle Financial Partners Inc. (PNFP) is a bank holding company operating primarily in Tennessee, North Carolina, South Carolina, and Virginia, providing a full range...
Viomi Technology Co. Ltd (VIOT) is a Chinese technology company developing smart home solutions and IoT products, providing connected appliances, home automation systems, and...